You can also call the appointment center to schedule, change or cancel an appointment or ask questions.
Beaumont Health System, with three hospitals in the northern Detroit suburbs serving southern Michigan and beyond, is a highly productive contributor to clinical trials across the nation. The Beaumont Research Institute, established by the hospital's Board of Trustees in 1966, strengthens Beaumont's ability to conduct medical research and to provide a research training experience for the medical staff and participants in graduate medical education programs.
Status: open and enrolling
Approval Date: 2/23/2013
Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults.
Approval Date: 12/10/2012
The purpose of this study is to evaluate the safety and effectiveness of a new drug in patients who have Staphylococcus aureus Bacteremia or with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia that continues even after at least 72 hours of antibiotic (vancomycin or daptomycin) treatment.
Approval Date: 11/1/2012
The purpose of this study is to evaluate the efficacy and safety of a continuous intravenous (IV) ularitide infusion on the clinical status and outcome of patients with acute decompensated heart failure (ADHF). ADHF is a condition in which the heart has lost the ability to pump enough blood. Ularitide is an investigational drug meaning that it has not yet been approved by the FDA for use.
Approval Date: 10/19/2012
The purpose of this study is to determine whether ceftaroline is effective and safe for the treatment of patients with Community-acquired Bacterial Pneumonia (CABP) at risk for infection due to Methicillin-resistant Staphylococcus aureus (MRSA).